These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9283804)

  • 21. Antihypertensive therapy, nifedipine, and autonomic dysreflexia.
    Frost F
    Arch Phys Med Rehabil; 2002 Sep; 83(9):1325-6; author reply 1326. PubMed ID: 12235621
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of isradipine and nifedipine retard in hypertensive patients with type II diabetes mellitus.
    Gomis R; Vidal J; Novials A; Coves MJ
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):102S-103S. PubMed ID: 8466715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rational approach to selection of antihypertensive therapy in persons with metabolic syndrome: efficacy of monotherapy with spirapril and its combination with retard form of nifedipine].
    Mamedov MN; Kiseleva NV
    Kardiologiia; 2006; 46(9):26-30. PubMed ID: 17047619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antihypertensive therapy on glucose tolerance: focus on calcium antagonists.
    Hedner T; Samuelsson O; Lindholm L
    J Intern Med Suppl; 1991; 735():101-11. PubMed ID: 2043219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus.
    Klauser R; Speiser P; Gisinger C; Schernthaner G; Prager R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S93-6. PubMed ID: 1695314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcium antagonists in arterial hypertension].
    Muiesan G
    G Ital Cardiol; 1988 Nov; 18(11):982-8. PubMed ID: 3073993
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of calcium antagonists on hypertension and diabetes in new hypertensive diabetic models.
    Sato T; Nara Y; Note S; Yamori Y
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S192-4. PubMed ID: 2455131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of antihypertensive drugs in pregnancy].
    Tsaava F; Shonia R
    Georgian Med News; 2005 Sep; (126):23-6. PubMed ID: 16234587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine intake increases the risk for periodontal destruction in subjects with type 2 diabetes mellitus.
    Li X; Luan Q; Wang X; Sha Y; He L; Cao C; Jin L
    J Periodontol; 2008 Nov; 79(11):2054-9. PubMed ID: 18980513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nifedipine on insulin secretion and glucose metabolism in rats and in hypertensive type 2 (non-insulin dependent) diabetics.
    Kanatsuna T; Nakano K; Mori H; Kano Y; Nishioka H; Kajiyama S; Kitagawa Y; Yoshida T; Kondo M; Nakamura N
    Arzneimittelforschung; 1985; 35(2):514-7. PubMed ID: 3888227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
    Derosa G; Querci F; Franzetti I; Dario Ragonesi P; D'Angelo A; Maffioli P
    Hypertens Res; 2015 Oct; 38(10):690-4. PubMed ID: 25994603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension.
    Koyama Y; Kodama K; Suzuki M; Harano Y
    Am J Hypertens; 2002 Nov; 15(11):927-31. PubMed ID: 12441210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetogenic effect of nifedipine.
    Heyman SN; Heyman A; Halperin I
    DICP; 1989 Mar; 23(3):236-7. PubMed ID: 2718503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cilnidipine, the N- and L-type calcium channel antagonist, reduced on 24-h urinary catecholamines and C-peptide in hypertensive non-insulin-dependent diabetes mellitus.
    Takeda S; Ueshiba H; Hattori Y; Irie M
    Diabetes Res Clin Pract; 1999 Jun; 44(3):197-205. PubMed ID: 10462143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nisoldipine: a replacement therapy for nifedipine in the treatment of severe hypertension.
    Grossman E; Rosenthal T
    Clin Cardiol; 1988 May; 11(5):325-8. PubMed ID: 3383470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Korinfar in the treatment of patients with arterial hypertension].
    Lautsevichus LZ; Kibarskis KhKh; Razukas VA; Nauiokaĭtene RS
    Vrach Delo; 1986 Sep; (9):26-8. PubMed ID: 3788106
    [No Abstract]   [Full Text] [Related]  

  • 37. Dangers, myths, controversy. Sublingual nifedipine for hypertensive crisis.
    Kaufman SE; Schneider EF
    JAAPA; 2000 Mar; 13(3):67-8, 71-4, 80. PubMed ID: 11503405
    [No Abstract]   [Full Text] [Related]  

  • 38. Risks and benefits of calcium antagonists.
    Lichtlen PR
    Lancet; 1995 Oct; 346(8980):962. PubMed ID: 7564741
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of nifedipine and nitrendipine on insulin secretion in obese patients.
    Valensi P; Uzzan B; Attali JR; Perret G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S91-3. PubMed ID: 1723467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the safety of short-acting nifedipine in children with hypertension.
    Egger DW; Deming DD; Hamada N; Perkin RM; Sahney S
    Pediatr Nephrol; 2002 Jan; 17(1):35-40. PubMed ID: 11793132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.